Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Bladder cancer, Transitional cell cancer
Closed
Phase 3
This trial is for people with non muscle invasive bladder cancer who are going to have treatment with BCG into the bladder for the first time.
Non muscle invasive bladder cancer means the cancer cells are only in the inner lining of the bladder.
Recruitment start: 19 November 2018
Recruitment end: 31 August 2020
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Hugh Mostafid
AstraZeneca
Last reviewed: 31 August 2020
CRUK internal database number: 15903